Translational outcomes in a full gene deletion of ubiquitin protein ligase E3A rat model of Angelman syndrome

Elizabeth L. Berg(University of California, Davis), Jill L. Silverman(Mining Institute), Kyle D. Fink(California Institute for Regenerative Medicine), Henriette O’Geen(University of California, Davis), Ulrika Beitnere(University of California, Davis), Kevin Nash(University of South Florida), Brian J. Nieman(Ontario Institute for Cancer Research), Peter Deng(California Institute for Regenerative Medicine), Scott V. Dindot(Ultragenyx Pharmaceutical (United States)), Anne E. Anderson(Baylor College of Medicine), Timothy A. Fenton(University of California, Davis), Stela P. Petkova(University of California, Davis), Michael C. Pride(University of California, Davis), Ruth D. Lee(University of California, Davis), Markus Wöhr(Allen Institute for Brain Science), Jason P. Lerch, David Cameron(California Institute for Regenerative Medicine), Anna Adhikari(University of California, Davis), Leigh Spencer Noakes(Hospital for Sick Children), Nycole A. Copping(University of California, Davis), Jacob Ellegood(Hospital for Sick Children), Melinda Peters(USF Health Byrd Alzheimer's Institute), David J. Segal(University of California, Davis), Sarah Harris(Baylor College of Medicine), Yanying Shen(Shanghai Jiao Tong University), Lauren R. Pedersen(University of California, Davis), Edwin J. Weeber(Society for Neuroscience), Heather A. Born(Baylor College of Medicine)
Translational Psychiatry
January 27, 2020
Cited by 65


Related Papers